Key alternative RAS components are reduced in inflamed colon in IBD: potential therapeutic targets

M Garg, SG Royce, C Tikellis, D Batu, C Shallue, P Sluka, H Wardan, E Velkoska, LM Burrell, M Thomas, A Mcfarlane, PR Gibson, JS Lubel